SCHEMBL26423116

SCHEMBL26423116

Cc1ccc2c(c1)c(C)nn2C(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.37
ADORA2B P29275 3/20 0.37
KDM4E B2RXH2 4/20 0.36
HSD17B10 Q99714 4/20 0.36
LMNA P02545 2/20 0.36
USP2 O75604 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NR1I2 O75469 1/20 0.34
AHR P35869 1/20 0.34
ALOX15 P16050 1/20 0.33
ALDH1A1 P00352 3/20 0.32
HPGD P15428 3/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ELANE P08246 1/20 0.32
PARP15 Q460N3 1/20 0.32
PARP14 Q460N5 1/20 0.32
PARP10 Q53GL7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23535755 0.83 MAPK8 (0.39) ADORA2AADORA2BLMNAMAPTNPSR1
SCHEMBL26423113 0.83 LMNA (0.34) KDM4EHSD17B10LMNAUSP2MAPT
SCHEMBL26262739 0.80 HTR1D (0.35) ADORA2AADORA2BHSD17B10MAPTTSHR
SCHEMBL30040207 0.78 HCAR3 (0.43) KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL23535775 0.78 HCAR3 (0.43) KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL29301497 0.78 ALDH1A1 (0.41) KDM4ELMNAMAPTMEN1KMT2A
SCHEMBL30041528 0.75 KDM4E (0.43) KDM4EHSD17B10MAPTMEN1KMT2A
SCHEMBL23535748 0.75 KDM4E (0.43) KDM4EHSD17B10MAPTMEN1KMT2A
SCHEMBL30147630 0.75 CCNC (0.40) ALDH1A1
SCHEMBL5985731 0.73 ADORA2A (0.63) ADORA2AADORA2BKDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF ARBUTUS BIOPHARMA CORP (CA) 2023-10-05 US disclosed
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF ARBUTUS BIOPHARMA CORP (CA) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF NSD3, PML, NSD1 ADORA2A 3769/4885ADORA2B 3685/4885KDM4E 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.